Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity

International Journal of Neuropsychopharmacology

Volumn 14, Issue 10, 2011, Pages 1367-1376

  Bergman, Olle ^a   Westberg, Lars ^a   Lichtenstein, Paul ^b   Eriksson, Elias ^a   Larsson, Henrik ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ADHD; BDNF; rs6265; Val 66Met

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; HUMAN; HYPERACTIVITY; IMPULSIVENESS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SWEDEN;

ADOLESCENT; ADOLESCENT BEHAVIOR; AGE FACTORS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; CHILD BEHAVIOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMPULSIVE BEHAVIOR; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 80054977096     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000502     Document Type: Article

References (52)

1. APA (1994). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Press. Banerjee TD, Middleton F, Faraone SV (2007). Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatrica 96, 1269-1274. (Pubitemid 47300704)
2. Brookes K, Xu X, Chen W, Zhou K, et al. (2006). The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder : association signals in DRD4, DAT1 and 16 other genes. Molecular Psychiatry 11, 934-953.
3. Chen ZY, Jing D, Bath KG, Ieraci A, et al. (2006). Genetic variant BDNF (Val66Met) polymorphism alters anxietyrelated behavior. Science 314, 140-143. (Pubitemid 44547760)
4. Chen ZY, Patel PD, Sant G, Meng CX, et al. (2004). Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. Journal of Neuroscience 24, 4401-4411. (Pubitemid 38608151)
5. Egan MF, Kojima M, Callicott JH, Goldberg TE, et al. (2003). The BDNF val66met polymorphism affects activitydependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269. (Pubitemid 36144114)
6. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, et al. (1999). High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. American Journal of Psychiatry 156, 1209-1215. (Pubitemid 29374881)
7. Faraone SV (2004). Genetics of adult attention-deficit/ hyperactivity disorder. Psychiatric Clinics of North America 27, 303-321. (Pubitemid 38452769)
8. Faraone SV, Biederman J, Monuteaux MC (2000). Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genetic Epidemiology 18, 1-16. (Pubitemid 30039195)
9. Faraone SV, Sergeant J, Gillberg C, Biederman J (2003). The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2, 104-113.
10. Flanagin BA, Cook EH, de Wit H (2006). An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141B, 576-583. (Pubitemid 44434657)
11. Gjone H, Novik TS (1995). Parental ratings of behaviour problems: a twin and general population comparison. Journal of Child Psychology and Psychiatry 36, 1213-1224.
12. Gratacos M, Gonzalez JR, Mercader JM, de Cid R, et al. (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders : meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 61, 911-922. (Pubitemid 46420580)
13. Hannelius U, Gherman L, Makela VV, Lindstedt A, et al. (2007). Large-scale zygosity testing using single nucleotide polymorphisms. Twin Research and Human Genetics 10, 604-625. (Pubitemid 47327023)
14. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, et al. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience 23, 6690-6694. (Pubitemid 36951196)
15. Henningsson S, Borg J, Lundberg J, Bah J, et al. (2009). Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men. Biological Psychiatry 66, 477-485.
16. Hyman C, Hofer M, Barde YA, Juhasz M, et al. (1991). BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232. (Pubitemid 21912205)
17. Jucaite A, Fernell E, Halldin C, Forssberg H, et al. (2005). Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder : association between striatal dopamine markers and motor hyperactivity. Biological Psychiatry 57, 229-238. (Pubitemid 40187366)
18. Kent L, Green E, Hawi Z, Kirley A, et al. (2005). Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Molecular Psychiatry 10, 939-943. (Pubitemid 41486486)
19. Knusel B, Beck KD, Winslow JW, Rosenthal A et al. (1992). Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. Journal of Neuroscience 12, 4391-4402.
20. Korte M, Carroll P, Wolf E, Brem G, et al. (1995). Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proceedings of the National Academy of Sciences USA 92, 8856-8860.
21. Kuntsi J, Rijsdijk F, Ronald A, Asherson P, et al. (2005). Genetic influences on the stability of attention-deficit/ hyperactivity disorder symptoms from early to middle childhood. Biological Psychiatry 57, 647-654. (Pubitemid 40409703)
22. Lanktree M, Squassina A, Krinsky M, Strauss J, et al. (2008). Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147B, 945-951.
23. Larsson H, Lichtenstein P, Larsson JO (2006). Genetic contributions to the development of ADHD subtypes from childhood to adolescence. Journal of the American Academy of Child and Adolescent Psychiatry 45, 973-981. (Pubitemid 44126872)
24. Larsson JO, Larsson H, Lichtenstein P (2004). Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: a longitudinal twin study. Journal of the American Academy of Child and Adolescent Psychiatry 43, 1267-1275. (Pubitemid 39281667)
25. Lasky-Su J, Faraone SV Lange C, Tsuang MT, et al. (2007). A study of how socioeconomic status moderates the relationship between SNPs encompassing BDNF and ADHD symptom counts in ADHD families. Behavioral Genetics 37, 487-497. (Pubitemid 46599035)
26. Lee J, Laurin N, Crosbie J, Ickowicz A, et al. 2007 Association study of the brain-derived neurotropic factor (BDNF) gene in attention deficit hyperactivity disorder American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144B 976-981. (Pubitemid 350207768)
27. Leibrock J, Lottspeich F, Hohn A, Hofer M, et al. (1989). Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341, 149-152. (Pubitemid 19222776)
28. Leo D, Sorrentino E, Volpicelli F, Eyman M, et al. (2003). Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neuroscience & Biobehavioral Reviews 27, 661-669. (Pubitemid 37414914)
29. Levy F, Hay D, McLaughlin M, Wood C, et al. (1996). Twin sibling differences in parental reports of ADHD, speech, reading and behaviour problems. Journal of Child Psychology and Psychiatry 37, 569-578. (Pubitemid 26196490)
30. Lichtenstein P, Tuvblad C, Larsson H, Carlstrom E (2007). The Swedish twin study of CHild and adolescent development : The TCHAD-study. Twin Research and Human Genetics 10, 67-73. (Pubitemid 46423377)
31. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, et al. (1999). Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proceedings of the National Academy of Sciences USA 96, 15239-15244. (Pubitemid 30019796)
32. McGee R, Prior M, Willams S, Smart D, et al. (2002). The long-term significance of teacher-rated hyperactivity and reading ability in childhood: findings from two longitudinal studies. Journal of Child Psychology and Psychiatry 43, 1004-1017. (Pubitemid 36939278)
33. McLoughlin G, Ronald A, Kuntsi J, Asherson P, et al. (2007). Genetic support for the dual nature of attention deficit hyperactivity disorder : substantial genetic overlap between the inattentive and hyperactive-impulsive components. Journal of Abnormal Child Psychology 35, 999-1008. (Pubitemid 47476575)
34. Meredith GE, Callen S, Scheuer DA (2002 Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Research 949, 218-227. (Pubitemid 35246197)
35. Monteggia LM, Barrot M, Powell CM, Berton O, et al. (2004). Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proceedings of the National Academy of Sciences USA 101, 10827-10832. (Pubitemid 38955827)
36. Narita M, Aoki K, Takagi M, Yajima Y, et al. (2003). Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119, 767-775. (Pubitemid 36694803)
37. Neves-Pereira M, Mundo E, Muglia P, King N, et al. 2002 The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder : evidence from a family-based association study American Journal of Human Genetics 71 651-655. (Pubitemid 34970137)
38. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, et al. (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience 24, 10099-10102. (Pubitemid 39492034)
39. Rios M, Fan G, Fekete C, Kelly J, et al. (2001). Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Molecular Endocrinology 15, 1748-1757. (Pubitemid 32939305)
40. Sanchez-Mora C, Ribases M, Ramos-Quiroga JA, Casas M, et al. (2010). Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B, 512-523.
41. Schimmelmann BG, Friedel S, Dempfle A, Warnke A, et al. (2007). No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD. Journal of Neural Transmission (SUPPL.) 114, 523-526. (Pubitemid 46474871)
42. Simonoff E, Pickles A, Meyer JM, Silberg JL, et al. (1997). The Virginia Twin Study of Adolescent Behavioral Development. Influences of age, sex, and impairment on rates of disorder. Archives of General Psychiatry 54, 801-808.
43. Sklar P, Gabriel SB, McInnis MG, Bennett P, et al. (2002). Family-based association study of 76 candidate genes in bipolar disorder : BDNF is a potential risk locus. Brain-derived neutrophic factor. Molecular Psychiatry 7, 579-593.
44. Szeszko PR, Lipsky R, Mentschel C, Robinson D, et al. (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry 10, 631-636. (Pubitemid 40961733)
45. Terracciano A, Sanna S, Uda M, Deiana B, et al. (2010). Genome-wide association scan for five major dimensions of personality. Molecular Psychiatry 15, 647-656.
46. Thapar A, Langley K, Owen MJ, O'Donovan MC (2007). Advances in genetic findings on attention deficit hyperactivity disorder. Psychological Medicine 37, 1681-1692. (Pubitemid 350100436)
47. Todd RD2000). Genetics of attention deficit/hyperactivity disorder : are we ready for molecular genetic studies? American Journal of Medical Genetics 96, 241-243.
48. Tsai SJ (2007). Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity : clinical and therapeutic implications. Medical Hypotheses 68, 896-899.
49. van Lier PA, van der Ende J, Koot HM, Verhulst FC (2007). Which better predicts conduct problems? The relationship of trajectories of conduct problems with ODD and ADHD symptoms from childhood into adolescence. Journal of Child Psychology and Psychiatry 48, 601-608. (Pubitemid 46902330)
50. Volkow ND, Wang GJ, Kollins SH, Wigal TL, et al. 2009 Evaluating dopamine reward pathway in ADHD: clinical implications Journal of the American Medical Association 302 1084-1091.
51. Willoughby MT (2003). Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations. Journal of Child Psychology and Psychiatry 44, 88-106. (Pubitemid 36943951)
52. Xu X, Mill J, Zhou K, Brookes K, et al. (2007). Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144B, 83-86. (Pubitemid 46122643)